Explore 25 life-threatening conditions that modern medicine can now handle. Witness incredible medical breakthroughs, from advanced diagnostics to new trea ...

A still image of Philip Fry from the Hulu animated series, Futurama. Hulu.com Futurama Season 14 dropped two episodes on Hulu this morning — and the show's first jokes are about technologies that ...

The prior three articles in this series — covering the theatrical premiere, the broadcast premiere, and Episode 1's deep physics dive — mapped The Calamity's power systems onto quantum decoherence, ...

The British Government acted unlawfully when removing some safeguards around gene editing for food. Transparency, consumer choice, organic production and trade are inseparable from questions about ...

A couple of decades after the discovery of systems that could selectively target DNA, we’re starting to see the first therapies based on gene editing. One challenge these developments have faced is ...

Scientists have made many advances using traditional CRISPR technology, especially in medicine, but they are now seeking ways to create genuinely new gene-editing enzymes with properties that have not ...

Analysis of one million diverse genomes yields mutations associated with lower risk of diabetes, heart disease and other ...

Gene editing is like a molecular meet cute. When protein “scissors” dock onto the intended gene, even a tiny slip—no more than the width of a hydrogen atom—can ruin the connection, and the protein may ...

A 6-year-old Chinese girl died last year after receiving an experimental gene therapy to correct a non-life-threatening condition, according to an investigation by Science and Retraction Watch. The ...

SHANGHAI – A young girl died after receiving an experimental gene-editing treatment in a clinical trial in Shanghai, Science Journal reported, raising questions about regulatory oversight and ...

WASHINGTON – A six-year-old Chinese girl died in 2025 after receiving an experimental gene therapy to correct a non-life-threatening condition, according to an investigation by Science and Retraction ...

The startup has completed enrollment of an early-stage study testing a first-of-its-kind treatment for facioscapulohumeral muscular dystrophy, a disease targeted by many other drugmakers.